Chugai Pharmaceutical Co., Ltd.
4519.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥11,517,806 | ¥8,788,706 | ¥5,539,680 | ¥6,140,900 |
| - Cash | ¥540,202 | ¥458,674 | ¥222,169 | ¥267,753 |
| + Debt | ¥10,897 | ¥13,455 | ¥14,109 | ¥16,040 |
| Enterprise Value | ¥10,988,501 | ¥8,343,487 | ¥5,331,620 | ¥5,889,187 |
| Revenue | ¥1,170,611 | ¥1,111,367 | ¥1,259,946 | ¥999,758 |
| % Growth | 5.3% | -11.8% | 26% | – |
| Gross Profit | ¥830,749 | ¥693,009 | ¥783,062 | ¥660,268 |
| % Margin | 71% | 62.4% | 62.2% | 66% |
| EBITDA | ¥574,796 | ¥475,644 | ¥562,660 | ¥450,301 |
| % Margin | 49.1% | 42.8% | 44.7% | 45% |
| Net Income | ¥387,317 | ¥325,472 | ¥374,429 | ¥302,995 |
| % Margin | 33.1% | 29.3% | 29.7% | 30.3% |
| EPS Diluted | 235.36 | 197.8 | 227.57 | 184.17 |
| % Growth | 19% | -13.1% | 23.6% | – |
| Operating Cash Flow | ¥447,600 | ¥409,925 | ¥244,112 | ¥279,626 |
| Capital Expenditures | -¥50,925 | -¥74,258 | -¥71,239 | -¥72,866 |
| Free Cash Flow | ¥396,675 | ¥335,667 | ¥172,873 | ¥206,760 |